Cargando…

Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial

AIMS: The SHIFT trial showed that ivabradine reduced heart rate (HR) and the risk of cardiovascular outcomes. Concerns remain over the efficacy and safety of ivabradine on heart failure (HF) due to Chagas disease (ChD). We therefore conducted a post hoc analysis of the SHIFT trial to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bocchi, Edimar Alcides, Rassi, Salvador, Guimarães, Guilherme Veiga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5933959/ https://www.ncbi.nlm.nih.gov/pubmed/29266804 http://dx.doi.org/10.1002/ehf2.12240

Ejemplares similares

Reply: Sacubitril/valsartan for Chagas' heart disease heart failure?
por: Bocchi, Edimar Alcides, et al.
Publicado: (2018)

Hydrotherapy in Heart Failure: A Case Report
por: Carvalho, Vitor Oliveira, et al.
Publicado: (2009)

The Relationship Between Heart Rate Reserve and Oxygen Uptake Reserve in Heart Failure Patients on Optimized and Non-Optimized Beta-Blocker Therapy
por: Carvalho, Vitor Oliveira, et al.
Publicado: (2008)

Reproducibility of the Self-Controlled Six-Minute Walking Test in Heart Failure Patients
por: Guimarães, Guilherme Veiga, et al.
Publicado: (2008)

Post hoc analyses of SHIFT and PARADIGM‐HF highlight the importance of chronic Chagas' cardiomyopathy Comment on: “Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial” by Bocchi et al.
por: Ramires, Felix J.A., et al.
Publicado: (2018)

Heart Rate Dynamics During A Treadmill Cardiopulmonary Exercise Test in Optimized Beta-Blocked Heart Failure Patients
por: Carvalho, Vitor Oliveira, et al.
Publicado: (2008)

Heart Failure in South America
por: Bocchi, Edimar Alcides
Publicado: (2013)

The course of patients with Chagas heart disease during episodes of decompensated heart failure
por: Issa, Victor Sarli, et al.
Publicado: (2021)

Chagas’ disease: the hidden enemy around the world
por: Bocchi, Edimar Alcides
Publicado: (2022)

Norepinephrine Remains Increased in the Six-Minute Walking Test after Heart Transplantation
por: Guimarães, Guilherme Veiga, et al.
Publicado: (2010)

Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure
por: Scanavacca, Mauricio, et al.
Publicado: (2018)

Quality of Life in Heart Failure: An Important Goal in Treatment
por: Gomes, Brenno Rizerio, et al.
Publicado: (2020)

Current strategies for preventing renal dysfunction in patients with heart failure: a heart failure stage approach
por: Issa, Victor Sarli, et al.
Publicado: (2013)

Bloqueio do Ramo Esquerdo Idiopático e Sintomas Inexplicáveis Durante o Exercício: Um Relato de Caso
por: Guimarães, Guilherme Veiga, et al.
Publicado: (2020)

Atrial fibrillation in heart failure with reduced ejection fraction: a case report of exercise training
por: Guimarães, Guilherme Veiga, et al.
Publicado: (2020)

Endothelial function in pre-pubertal children at risk of developing cardiomyopathy: a new frontier
por: Tavares, Aline Cristina, et al.
Publicado: (2012)

Functional Class in Children with Idiopathic Dilated Cardiomyopathy. A pilot Study
por: Tavares, Aline Cristina, et al.
Publicado: (2016)

Three and two-dimensional cardiac mechanics by speckle tracking are predictors of outcomes in chagas heart disease
por: Hotta, Viviane Tiemi, et al.
Publicado: (2022)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
por: Franke, Jennifer, et al.
Publicado: (2011)

Determinants of peak VO(2) in heart transplant recipients
por: Carvalho, Vitor Oliveira, et al.
Publicado: (2015)

Sex Differences in Prognosis of Heart Failure Due to Ischemic and Nonischemic Cardiomyopathy
por: Mansur, Antonio de Padua, et al.
Publicado: (2023)

Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study
por: Borer, Jeffrey S., et al.
Publicado: (2012)

Heart Failure Awareness Day: A Tribute to the Genius Carlos Chagas
por: Mesquita, Evandro Tinoco, et al.
Publicado: (2019)

Clinical findings and prognosis of patients hospitalized for acute decompensated heart failure: Analysis of the influence of Chagas etiology and ventricular function
por: Terhoch, Caíque Bueno, et al.
Publicado: (2018)

Levosimendan treatment for acutely decompensated heart failure is as effective for Chagas disease patients as for patients with other etiologies
por: Pereira-Barretto, AC, et al.
Publicado: (2003)

Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016)

Angiotensin-Converting Enzyme ID Polymorphism in Patients with Heart Failure Secondary to Chagas Disease
por: da Silva, Silene Jacinto, et al.
Publicado: (2017)

Archaea Symbiont of T. cruzi Infection May Explain Heart Failure in Chagas Disease
por: Higuchi, Maria de Lourdes, et al.
Publicado: (2018)

Safety and efficacy of off-label use of ivabradine in patients with acute heart failure
por: Othman, Khaled M. Said, et al.
Publicado: (2019)

Impact of ivabradine in decompensated heart failure due to cancer therapy‐related cardiac dysfunction
por: Nakano, Yusuke, et al.
Publicado: (2021)

Mode of Death on Chagas Heart Disease: Comparison with Other Etiologies. A Subanalysis of the REMADHE Prospective Trial
por: Ayub-Ferreira, Silvia M., et al.
Publicado: (2013)

Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
por: Rohm, Ilonka, et al.
Publicado: (2016)

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
por: Kansal, Anuraag R., et al.
Publicado: (2016)

Ivabradine in Congestive Heart Failure: Patient Selection and Perspectives
por: Sattar, Yasar, et al.
Publicado: (2019)

Efficacy of ivabradine in heart failure patients with a high‐risk profile (analysis from the SHIFT trial)
por: Abdin, Amr, et al.
Publicado: (2023)

Echocardiographic Parameters and Survival in Chagas Heart Disease with Severe Systolic Dysfunction
por: Rassi, Daniela do Carmo, et al.
Publicado: (2014)

Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
por: Urbanek, Irmina, et al.
Publicado: (2014)

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fnvomsl74ck2l9b0otejfj8hnd